Kuczynski J, Lauber CL, Walters WA, et al. Experimental and analytical tools for studying the human microbiome. Nat Rev Genet. 2011;13(1):47-58. doi:10.1038/nrg3129
Sczesnak A, Segata N, Qin X, et al. The genome of th17 cell-inducing segmented filamentous bacteria reveals extensive auxotrophy and adaptations to the intestinal environment. Cell Host Microbe. 2011;10(3):260-72. doi:10.1016/j.chom.2011.08.005
Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60. doi:10.1186/gb-2011-12-6-r60
Yilmaz P, Kottmann R, Field D, et al. Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specifications. Nat Biotechnol. 2011;29(5):415-20. doi:10.1038/nbt.1823
Zella GC, Hait EJ, Glavan T, et al. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm Bowel Dis. 2011;17(5):1092-100. doi:10.1002/ibd.21460
Human Microbiome Jumpstart Reference Strains Consortium, Nelson KE, Weinstock GM, et al. A catalog of reference genomes from the human microbiome. Science. 2010;328(5981):994-9. doi:10.1126/science.1183605
Fomina-Yadlin D, Kubicek S, Vetere A, et al. GW8510 increases insulin expression in pancreatic alpha cells through activation of p53 transcriptional activity. PLoS One. 2012;7(1):e28808. doi:10.1371/journal.pone.0028808
Reed JC, White L, Aubé J, et al. The NIH’s role in accelerating translational sciences. Nat Biotechnol. 2012;30(1):16-9. doi:10.1038/nbt.2087
Biffi A, Shulman JM, Jagiella JM, et al. Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology. 2012;78(5):334-41. doi:10.1212/WNL.0b013e3182452b40
Vitti JJ, Cho MK, Tishkoff SA, Sabeti PC. Human evolutionary genomics: ethical and interpretive issues. Trends Genet. 2012;28(3):137-45. doi:10.1016/j.tig.2011.12.001